Loading...
Cross Country Healthcare, Inc.
CCRN•NASDAQ
Healthcare
Medical - Care Facilities
$13.60
$0.010(0.07%)
Cross Country Healthcare, Inc. (CCRN) Financial Performance & Income Statement Overview
Review Cross Country Healthcare, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-33.46%
↓ 33.46%
Operating Income Growth
-114.96%
↓ 114.96%
Net Income Growth
-120.04%
↓ 120.04%
Operating Cash Flow Growth
-51.66%
↓ 51.66%
Operating Margin
-1.16%
↓ 1.16%
Gross Margin
19.60%
↑ 19.60%
Net Profit Margin
-1.41%
↓ 1.41%
ROE
-4.17%
↓ 4.17%
ROIC
-3.12%
↓ 3.12%
Cross Country Healthcare, Inc. (CCRN) Income Statement & Financial Overview
Review Cross Country Healthcare, Inc.'s (CCRN) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $309.94M | $315.12M | $339.77M | $379.17M |
Cost of Revenue | $247.95M | $250.96M | $273.69M | $306.52M |
Gross Profit | $61.99M | $64.16M | $66.09M | $72.66M |
Gross Profit Ratio | $0.20 | $0.20 | $0.19 | $0.19 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $35.42M | $54.30M | $79.12M | $64.54M |
Operating Expenses | $65.42M | $64.16M | $79.12M | $64.54M |
Total Costs & Expenses | $313.37M | $312.27M | $352.80M | $371.06M |
Interest Income | $535000.00 | $1.11M | $0.00 | $0.00 |
Interest Expense | $608000.00 | $550000.00 | $568000.00 | $462000.00 |
Depreciation & Amortization | $4.34M | $4.50M | $4.72M | $4.64M |
EBITDA | $1.03M | $8.44M | -$14.28M | $8.79M |
EBITDA Ratio | $0.003 | $0.03 | -$0.04 | $0.02 |
Operating Income | -$3.43M | $2.85M | -$13.03M | $8.11M |
Operating Income Ratio | -$0.01 | $0.009 | -$0.04 | $0.02 |
Other Income/Expenses (Net) | -$481000.00 | $536000.00 | -$356000.00 | $768000.00 |
Income Before Tax | -$3.91M | $3.39M | -$19.56M | $3.69M |
Income Before Tax Ratio | -$0.01 | $0.01 | -$0.06 | $0.010 |
Income Tax Expense | -$161000.00 | $834000.00 | -$3.51M | $997000.00 |
Net Income | -$3.75M | $2.56M | -$16.05M | $2.69M |
Net Income Ratio | -$0.01 | $0.008 | -$0.05 | $0.007 |
EPS | -$0.12 | $0.08 | -$0.47 | $0.08 |
Diluted EPS | -$0.12 | $0.08 | -$0.47 | $0.08 |
Weighted Avg Shares Outstanding | $32.34M | $33.02M | $33.96M | $34.22M |
Weighted Avg Shares Outstanding (Diluted) | $32.34M | $33.06M | $33.96M | $34.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan